Long term response 20 years after yellow fever vaccination

Long term response after yellow fever vaccination - long term respons yellow fever vaccination

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON61343

Enrollment

100

Registered

2026-04-21

Start date

2026-07-16

Completion date

Unknown

Last updated

2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

yellow fever yellow fever

Interventions

not applicable (yellow fever vaccine which was administered in a previous study)

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: participant of a previous yellow fever vaccination studie at the LUMC

Exclusion criteria

Exclusion criteria: having received a yellow fever vaccine after participation in the trialbegin immuunocompromised (developed a disease with immune disorder or taking immunosuppressants)having a potential yellow fever infection 

Design outcomes

Primary

Measure	Time frame
yellow fever neutralising antibody titers	—

Secondary

Measure	Time frame
exploratory: cellular markers of long term protection against yellow fever	—

Countries

Netherlands

Contacts

Public ContactAHE Roukens

Leids Universitair Medisch Centrum

infectieziektenpoli@lumc.nl0715262613

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026